Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis
article
OA: gold
CC0
⤵ 2 in-corpus citations
Abstract
BACKGROUND: Our study aimed to examine the osteopontin (OPN) serum levels and tissue expression of CD44 and OPN in endometriosis-affected women both undergoing and not undergoing progestin treatment, and also to determine their involvement in the pathogenesis of endometriosis. METHODS: Using an ELISA kit, we evaluated the OPN serum levels of healthy and endometriosis-affected women both undergoing and not undergoing progestin treatment. Immunohistochemical (IHC) analyses were used to assess the endometriotic tissue expressions of CD44 and OPN. RESULTS: There were statistically significant higher OPN serum levels in the healthy control group compared to the women with endometriosis. Furthermore, there were higher OPN serum levels in the endometriosis-affected women undergoing the progestin treatment, but the difference did not reach statistical significance. In comparison to OPN, CD44 expression was significantly higher in all the endometriotic tissue glands and stroma, regardless of the patient's treatment status. Compared to the group receiving therapy, the OPN levels were higher in the endometriosis group not receiving therapy. OPN's robust cytoplasmic expression seemed to be associated with the non-treatment group. CONCLUSION: Endometriosis, CD44, and OPN appear to be closely related. This study suggests that endometriosis that has not been treated has an immunological profile distinct to endometriosis that has received treatment.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (61)
- Antiangiogenic Therapy as a New Strategy in the Treatment of Endometriosis? The First Case Report via openalex
- Blood biomarkers for the non-invasive diagnosis of endometriosis via openalex
- CD44s Expression is Reduced in Endometriotic Lesions Compared to Eutopic Endometrium in Women with Endometriosis via openalex
- Cellular, Histologic, and Molecular Changes Associated With Endometriosis and Ovarian Cancer via openalex
- Clinical characteristics and pregnancy outcomes of infertile patients with endometriosis and endometrial polyps: A retrospective cohort study via openalex
- Diagnosis and management of endometriosis via openalex
- Disturbed progesterone signalling in an advanced preclinical model of endometriosis via openalex
- Endometriose via openalex
- Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology via openalex
- Estrogen-progestins and progestins for the management of endometriosis via openalex
- Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis via openalex
- Expression of CD44 in endometrial stromal cells from women with and without endometriosis and its effect on the adherence to peritoneal mesothelial cells via openalex
- Expression of CD44s, vascular endothelial growth factor, matrix metalloproteinase-2 and Ki-67 in peritoneal, rectovaginal and ovarian endometriosis. via openalex
- Gene Expression Profiling of the Rat Endometriosis Model via openalex
- Hyaluronic Acid-Modified Nanoplatforms as a Vector for Targeted Delivery of Autophagy-Related Gene to the Endometriotic Lesions in Mice via openalex
- Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation via openalex
- Immunohistochemical expression of CD44v9 and 8‐OHdG in ovarian endometrioma and the benign endometriotic lesions adjacent to clear cell carcinoma via openalex
- Impaired Development of Early Endometriotic Lesions in CD44 Knockout Mice via openalex
- Impaired Down-Regulation of E-Cadherin and β-Catenin Protein Expression in Endometrial Epithelial Cells in the Mid-Secretory Endometrium of Infertile Patients with Endometriosis via openalex
- Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions via openalex
- <p>Real-World Characterization of Women with Diagnosed Endometriosis Initiating Therapy with Elagolix Using a US Claims Database</p> via openalex
- Medical treatment of endometriosis-related pain via openalex
- New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments via openalex
- ORIGINAL ARTICLE: Endometrial Osteopontin mRNA Expression and Plasma Osteopontin Levels are Increased in Patients with Endometriosis via openalex
- Osteopontin Regulates Endometrial Stromal Cell Migration in Endometriosis through the PI3K Pathway via openalex
- Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells via openalex
- Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis via openalex
- Possible Involvement of CD10 in the Development of Endometriosis Due to Its Inhibitory Effects on CD44-Dependent Cell Adhesion via openalex
- Serum Osteopontin Levels Are Decreased in Focal Adenomyosis via openalex
- The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study via openalex
- The direct and indirect costs associated with endometriosis: a systematic literature review via openalex
- Theories on the Pathogenesis of Endometriosis via openalex
- Tissue-specific somatic stem-cell isolation and characterization from human endometriosis. Key roles in the initiation of endometrial proliferative disorders. via openalex
- Ultrastructural Investigation of Pelvic Peritoneum in Patients With Chronic Pelvic Pain and Subtle Endometriosis in Association With Chromoendoscopy via openalex
- Whole-Exome Sequencing of Rare Site Endometriosis-Associated Cancer via openalex
- W3180291523 via openalex
- W1992454030 via openalex
- W4206485580 via openalex
- W4211081176 via openalex
- W4249074488 via openalex
- W1750523482 via openalex
- W4307883752 via openalex
- W4311821306 via openalex
- W6714806444 via openalex
- W6714839012 via openalex
- W6830848849 via openalex
- W2171825112 via openalex
- W2166351608 via openalex
- W2126377736 via openalex
- W2118180060 via openalex
- W2759760274 via openalex
- W2772343293 via openalex
- W2790339676 via openalex
- W2946962077 via openalex
- W2045970621 via openalex
- W2037100155 via openalex
- W3062144999 via openalex
- W3081226641 via openalex
- W3092542459 via openalex
- W3099845593 via openalex
- W3128919858 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-04T00:33:39.328528+00:00
License: CC0
· commercial use OK